Key points are not available for this paper at this time.
Shareable abstract Primary idiopathic hypereosinophilic syndrome is a rare condition that can cause end-organ damage in multiple systems. The advent of targeted monoclonal antibodies, such as mepolizumab, provides a safe and effective steroid-sparing treatment.https://bit.ly/4bgDP1u
Kuek et al. (Fri,) studied this question.